Publicaciones (218) Publicaciones en las que ha participado algún/a investigador/a

2021

  1. 27-hydroxycholesterol promotes oligodendrocytic maturation: Implications for Alzheimer's disease

    Alzheimer's & dementia : the journal of the Alzheimer's Association, Vol. 17, pp. e050497

  2. A European observational study to evaluate the safety and the effectiveness of safinamide in routine clinical practice: The SynapSES trial

    Journal of Parkinson's Disease, Vol. 11, Núm. 1, pp. 187-198

  3. A More Homogeneous Phenotype in Parkinson's Disease Related to R1441G Mutation in the LRRK2 Gene

    Frontiers in Neurology, Vol. 12

  4. A longitudinal study of gene expression in first-episode schizophrenia; exploring relapse mechanisms by co-expression analysis in peripheral blood

    Translational Psychiatry, Vol. 11, Núm. 1

  5. A multicentre validation study of the diagnostic value of plasma neurofilament light

    Nature Communications, Vol. 12, Núm. 1

  6. A multicentre, randomised, controlled trial of a combined clinical treatment for first-episode psychosis

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 14

  7. A systematic review of suicide and suicide attempts in adolescents with psychotic disorders

    Schizophrenia Research, Vol. 235, pp. 80-90

  8. Acute Δ9-tetrahydrocannabinol prompts rapid changes in cannabinoid CB1 receptor immunolabeling and subcellular structure in CA1 hippocampus of young adult male mice

    Journal of Comparative Neurology, Vol. 529, Núm. 9, pp. 2332-2346

  9. Alfa-sinukleina biomarkatzaile gisa Parkinson gaixotasunaren diagnostikoan

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 41, pp. 11-29

  10. Algunas reflexiones sobre la disforia de género

    Aperturas psicoanalíticas: Revista de psicoanálisis, Núm. 66

  11. Allosteric modulation of GSK‐3β as a new therapeutic approach in limb girdle muscular dystrophy R1 Calpain 3‐related

    International Journal of Molecular Sciences, Vol. 22, Núm. 14

  12. Alzheimer's disease neuropathology is exacerbated following traumatic brain injury. Neuroprotection by co-administration of nanowired mesenchymal stem cells and cerebrolysin with monoclonal antibodies to amyloid beta peptide

    Progress in Brain Research (Elsevier B.V.), pp. 1-97

  13. Amyotrophic lateral sclerosis (ALS), cancer, autoimmunity and metabolic disorders: An unsolved tantalizing challenge

    British Journal of Pharmacology, Vol. 178, Núm. 6, pp. 1269-1278

  14. Annual Research Review: Prevention of psychosis in adolescents – systematic review and meta-analysis of advances in detection, prognosis and intervention

    Journal of Child Psychology and Psychiatry and Allied Disciplines, Vol. 62, Núm. 5, pp. 657-673

  15. Association between coffee consumption and total dietary caffeine intake with cognitive functioning: cross-sectional assessment in an elderly Mediterranean population

    European Journal of Nutrition, Vol. 60, Núm. 5, pp. 2381-2396

  16. Astrocytes in Alzheimer's Disease: Pathological Significance and Molecular Pathways

    Cells, Vol. 10, Núm. 3

  17. Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation

    npj Parkinson's Disease, Vol. 7, Núm. 1

  18. Author Correction: BASP1 labels neural stem cells in the neurogenic niches of mammalian brain (Scientific Reports, (2021), 11, 1, (5546), 10.1038/s41598-021-85129-1)

    Scientific Reports

  19. Autoimmune encephalitis and related disorders: A retrospective study of 43 cases in a tertiary hospital

    Neurology Perspectives, Vol. 1, Núm. 4, pp. 197-205

  20. Autophagy and the hallmarks of aging

    Ageing Research Reviews, Vol. 72